Effects of pioglitazone on the incidence of dementia in patients with diabetes.

@article{Chou2017EffectsOP,
  title={Effects of pioglitazone on the incidence of dementia in patients with diabetes.},
  author={Ping-Song Chou and B V Ho and Yuan-Han Yang},
  journal={Journal of diabetes and its complications},
  year={2017},
  volume={31 6},
  pages={1053-1057}
}
AIMS Peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists exert neuroprotective effects in the brain. Therefore, in this population-based cohort study, we investigated the effects of pioglitazone, a PPAR-γ agonist, on the risk of dementia. METHODS By using claims data from Taiwan's National Health Insurance Research Database, we included 6401 patients with diabetes who were treated with pioglitazone and 12,802 age- and sex-matched patients with diabetes who were never treated… CONTINUE READING